Trials / Recruiting
RecruitingNCT06585852
Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid (RGD) in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement
Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid (RGD) in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement. A Randomized Clinical Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The aim of the present study is to evaluate the efficacy of xenograft alone or xenograft mixed with Arginylglycylaspartic acid (RGD) , in horizontal ridge augmentation with split-crest technique, for implant placement.
Detailed description
A comparative study for ridge augmentation procedure, With two groups. First group underwent a surgical ridge splitting procedure with ultrasonic bone surgery and grafting with Xenograft alone and implant placement. Second group underwent a surgical ridge splitting procedure with ultrasonic bone surgery Xenograft mix ed with Arginylglycylaspartic acid (RGD) and implant placement. Both groups were followed up for 1 and 3 months after loading.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RGD | Study group main material |
| DRUG | Xenograft | Scaffold material of choice |
| PROCEDURE | Split crest technique | Piezoelectric surgery |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2024-09-01
- Completion
- 2024-10-15
- First posted
- 2024-09-19
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06585852. Inclusion in this directory is not an endorsement.